Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Prochorec-Sobieszek
M. Prochorec-Sobieszek
Medicine
in patient
Internal medicine
Oncology
Pembrolizumab
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P37.09 Comparison of 3 Different Methods for Determination of EGFR p.Thr790Met mutation in patients with NSCLC
2021
Journal of Thoracic Oncology
A. Tysarowski
K. Seliga
Aleksandra Gos
A. Nowak
R. Zub
B. Jagielska
A. Płużański
Maciej Krzakowski
M. Prochorec-Sobieszek
Janusz A. Siedlecki
Show All
Source
Cite
Save
Citations (0)
P78.08 Prediction of Pembrolizumab Efficacy in Non-Small-Cell Lung Cancer (NSCLC) Based on Experience From Expanded Access Program in Poland
2021
Journal of Thoracic Oncology
M. Knetki-Wróblewska
Dariusz M. Kowalski
Adam Pluzanski
O. Stanowska
P. Wiśniewski
Kinga Winiarczyk
M. Zaborowska-Szmit
K Zajda
M. Prochorec-Sobieszek
Maciej Krzakowski
Show All
Source
Cite
Save
Citations (0)
P37.02 Identification of Gene Fusions and Mutations in Patients with NSCLC using two Diagnostic Approaches: Rapid qPCR and NGS
2021
Journal of Thoracic Oncology
A. Tysarowski
K. Seliga
A. Nowak
M. Wagrodzki
Aleksandra Gos
R. Zub
K. Olszewska
B. Jagielska
M. Knetki-Wróblewska
Adam Pluzanski
Maciej Krzakowski
Janusz A. Siedlecki
M. Prochorec-Sobieszek
Show All
Source
Cite
Save
Citations (0)
1